AzTrials
AzTrials

AnkyloglossiaANK-PROSNCT07512765

Ankyloglossia and Its Effects on Breastfeeding, Feeding and Speech Disorders. A Prospective Study From Birth to 4 Years of Age.

An observational study of Ankyloglossia and Breastfeeding, run by Erasme University Hospital at 1 site in Belgium.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The diagnosis of ankyloglossia (restrictive lingual frenulum) and the number of frenotomies in infants have sharply increased, raising concerns among the medical community and the ONE. Read more about this study

Who is it for?
Ages 1 day to 5 daysHealthy volunteers can take part
What is being tested?
TABBY, Lingual Frenulum Protocol with Scores for Infants. and Hazelbaker Assessment Tool for Lingual Frenulum Function
Type of treatment
Pill or oral medicine
How many people
348 participants
Where
1 siteBelgium
Study dates
23 May 2022to 31 Dec 2028
How long will I take part?
4 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 5 days
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Healthy newborns at the maternity ward of Erasme Hospital, Anderlecht, born between 23/05/2022 and 30/09/2024.

Who may be able to join

  • Newborn infant with a gestational age ≥ 37 weeks admitted to the postnatal ward of Hospital Erasmus- 1 to 5 days old
  • Mother intends to breastfeed at the postnatal ward
  • At least one parent has a good understanding of French

Who cannot join

  • Newborns will be excluded from the study if they present any of the following:
  • Severe medical conditions, including congenital oropharyngeal malformations (e.g. cleft lip, heart defects or brain anomalies) or Prader-Willi syndrome, sepsis, intrauterine growth restriction, need for intensive care
  • A positive COVID-19 test (for either the newborn or parents)
  • Multiple births (twins, triplets)
  • Parents under psychosocial surveillance

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Hopital Erasme

    Brussels, Anderlecht, 1070

Other trials in Belgium

About this study

The diagnosis of ankyloglossia (restrictive lingual frenulum) and the number of frenotomies in infants have sharply increased, raising concerns among the medical community and the ONE. While some studies suggest benefits of frenotomy on breastfeeding, all emphasize the lack of consensus regarding the definition, diagnosis, and classification of ankyloglossia, as well as the scarcity of prospective data on its impact on breastfeeding, feeding, occlusion, and speech.

This prospective study aims to determine whether lingual frenulum characteristics influence early breastfeeding difficulties and duration, as well as later feeding, occlusion, and speech outcomes. Breastfed newborns are followed from the first days of life (T1) to age 4 years (T7). During the first 3 months, tongue mobility, frenulum characteristics, breastfeeding, maternal pain, and complications are assessed. Several clinical tools are compared to identify the most reliable ones. Frenulum length is measured using calibrated photographs.

Read more

Phone follow-ups at 6 months, 1 and 2 years assess feeding outcomes; speech and occlusion are evaluated at 4 years.

This project could provide objective data to guide clinicians in evaluating ankyloglossia and making informed frenotomy decisions, improve breastfeeding support, and help parents make evidence-based choices.

Read the detailed description

Design: Prospective longitudinal study. The study was approved by the Ethics Committee of Erasme Hospital on May 4, 2022 (Reference : P2022/167/B4062021000404).

Newborns and their mother are recruited at Maternity Ward of Erasme Hospital, HUB Belgium. The dyads are then been followed up to the age of 4 years through clinical examinations, questionnaires and phone calls. Assessments at 6 weeks and 3 months of age are conducted to analyze early outcomes.

Sample size:

Sample size was calculated as follows, based on the calculation of Souza-Oliveira et al.20 : we considered 4.8% incidence of ankyloglossia in newborns based on the study by Messner et al. (2000), a margin of error of 3.0%, and 99.0% of confidence interval. The minimum sample size was 337. From 2022 to 2024, we have already completed our sample recruiting 348 in order to compensate for possible losses in the follow-up.

Primary outcomes: pain during breastfeeding (VAS and Mc Gill Pain Questionary), breastfeeding duration (days), presence of crackled nipples, engorgement, mastitis, nipple bleeding, abscess (breastfeeding complications).

Secondary outcomes:

  • frenulum length and width at birth, 1 month, 3 months of life.
  • breastfeeding assessment scales: LATCH score, Bristol Breastfeeding Assessment Tool (BBAT), NOMAS (Neonatal Oral-Motor Assessment Scale), Infant Breastfeeding Assessment Tool (IBFAT), Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF).
  • Ankyloglossia scales: Hazelbaker Assessment Tool for Lingual Frenulum Function (HATLFF)1, the Tongue-tie and Breastfed Babies (TABBY) scale2, the Lingual Frenulum Protocol with Scores for Infants (LFPI)4, the Coryllos scale3 and the Baxter Infant Examination Form21.
  • Muscle tension and joint mobility as manually assessed by an osteopath, and data's from The Myoton Pro (© 2016 Myoton AS), a non-invasive device designed to assess tone, stiffness, elasticity, relaxation time and tissue deformation, on the following muscles: sternocleidomastoid, trapezius, mylohyoid.

AMG-Pediatrics SCIENTIFIC SECTION- 4

Conduction of the Research :

The study has been conducted as follows:

T1 : between 1 and 5 days of the newborn's life, at the postnatal ward, a duo of an osteopath and a pediatrician performed examinations to assess:

  1. Newborn's assessment:
  2. Neurological status: evaluated using the Amiel-Tison and Gosselin Neurological Assessment from Birth to 6 Years (ENAT) scale, as part of the standard pediatric examination
  3. Oral anatomy and function: The baby's frenulum is assessed using multiple standardized scales (HATLFF1, TABBY2, Coryllos3, LFPI4, and Baxter Infant Examination Form). A calibrated photographic measurement is taken to assess tongue frenulum's length and width: the tongue was lifted with the examinator's two fingers and a picture of the baby's mouth was taken. A calibration is then used to calculate the length of the frenulum on the picture, using pixelization, by measuring the distance between its origin and insertion. The reliability and reproducibility of these measurements were assessed prior to the study, yielding a Cronbach's alpha of 0.99 and intraclass correlation coefficients (ICC) for interobserver and intraobserver reproducibility of 0.81 and 0.99, respectively.
  4. Muscle tension, joint mobility and cranial asymmetry: evaluated via manual osteopathic palpation and Myoton Pro (© 2016 Myoton AS) measurement on specific muscles (sternocleidomastoid, trapezius, mylohyoid).
  5. Maternal assessment:
  • Medical record review (pregnancy, delivery, breastfeeding-related factors).
  • Additional questions related to breastfeeding: previous experience in breastfeeding, duration, reasons for abandoning etc...
  • Assessment of maternal well-being: Edinburgh postnatal depression scale (EPDS)21, visual analogue scale for anxiety and fatigue, as those factors are known to influence breastfeeding duration.

During breastfeeding:

  • observational scales: BSES-SF, IBFAT, NOMAS, LATCH and BBAT.
  • optional videorecording of breastfeeding.
  • breastfeeding pain assessment: VAS and McGill Pain Questionnaire.

T2 : At 6 weeks postpartum, after the medical postnatal exam:

  • Reassessment of tongue function, oral anatomy, calibrated photography and osteopathic findings (same as T1).
  • Breastfeeding evaluation (if continuing) including weight monitoring before/during/after feeding, using OFS-T scale.
  • Additional maternal and infant assessments: reflux symptoms (GSQ-I), EPDS, VAS for fatigue/anxiety, Baxter Infant Questionnaire.
  • Questions about breastfeeding complications: crackled nipples, engorgement, mastitis, abscess, nipple bleeding.

T3 : At 3 months of age: the same evaluation as T2 are conducted in the parent's home.

T4, T5 and T6: At 6 months, 1 year, and 2 years, structured phone interviews are tracking breastfeeding duration, food diversification problems, feeding behaviors, teething, motor and language development, and sleep patterns.

T7 : At 4 years: in-person assessments include lingual frenulum (Coryllos scale, photographic measurements), dental occlusion (baby-ROMA index), speech and language development (Hénin grid, Evalo 2-6, NEEL phonological/articulation test), and parental questionnaires on language and behavior.

Being tested
TABBY, Lingual Frenulum Protocol with Scores for Infants., Hazelbaker Assessment Tool for Lingual Frenulum Function, Tongue Tie Measurement, Coryllos Scale
Keywords
Prospective study on ankyloglossia, ankyloglossia, tongue tie, ankyloglossia tools, ankyloglossia scales, ankyloglossia outcomes, ankyloglossia breastfeeding
Medical subject headings
Ankyloglossia, Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TABBYOther

    Assessment of tongue mobility and tongue tie with the TABBY scale at birth, 6 weeks and 3 months of age .

  • Lingual Frenulum Protocol with Scores for Infants.Other

    Also called Martinelli

    Assessment of tongue mobility, function, tongue tie anatomy, nutritive and non nutritive suck using LFPI (Martinelli Scale) at birth, 6 weeks and 3 months of age.

  • Hazelbaker Assessment Tool for Lingual Frenulum FunctionOther

    Also called HATLFF

    Assessment of tongue mobility, function and tongue tie anatomy at birth, 6 weeks and 3 months.

  • Tongue Tie MeasurementOther

    A calibrated photographic measurement is taken at birth, 6 weeks and 3 months to assess tongue frenulum's length and width: the tongue was lifted with the examinator's two fingers and a picture of the baby's mouth was taken. A calibration was then used to calculate the length of the frenulum on the picture, using pixelization, by measuring the distance between its origin and insertion

  • Coryllos ScaleOther

    Assessment of the lingual frenulum with the Corollas scale at birth, 6 weeks and 3 months of age

  • Breastfeeding Self Efficacy Scale - Short FormOther

    Also called BSES-SF

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the Breastfeeding Self Efficacy Scale - Short Form

  • Bristol Breastfeeding Assessment ToolOther

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the Bristol Breastfeeding Assessment Tool

  • Infant Breastfeeding Assessment ToolOther

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the Infant Breastfeeding Assessment Tool

  • Neonatal Oral-Motor Assessment ScaleOther

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the Neonatal Oral-Motor Assessment Scale

  • LATCH scoreOther

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the LATCH-Score

  • Nipple pain assessmentOther

    Nipple pain assessment using VAS and the Mc Gill Pain Questionary

Study groups in NCT07512765
Study groupRoleWhat they receive
Healthy newbornsNewborns will be followed up and assessed for ankyloglossia using TABBY, ATLFF, LFPI and Coryllos scales
Receives: Other: TABBY; Other: Lingual Frenulum Protocol with Scores for Infants.; Other: Hazelbaker Assessment Tool for Lingual Frenulum Function; Other: Tongue Tie Measurement; Other: Coryllos Scale; Other: Bristol Breastfeeding Assessment Tool; Other: Infant Breastfeeding Assessment Tool; Other: Neonatal Oral-Motor Assessment Scale; Other: LATCH score
Breastfeeding mothersNot described
Receives: Other: Breastfeeding Self Efficacy Scale - Short Form; Other: Bristol Breastfeeding Assessment Tool; Other: Infant Breastfeeding Assessment Tool; Other: Neonatal Oral-Motor Assessment Scale; Other: LATCH score; Other: Nipple pain assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Breastfeeding duration

    Duration of breastfeeding in days

    Measured: From enrollment to the end of the study at 4 years

Secondary outcomes (13)
  1. Tongue tie length and growth

    Tongue tie length at birth, 6 weeks and 3 months, measured by calibrated photographic measurement. A calibration was then used to calculate the length of the frenulum on the picture, using pixelization, by measuring the distance between its origin and insertion.

    Measured: At birth, 6 weeks of age and 3 months of age

  2. Pain during breastfeeding

    pain during breastfeeding at birth, 6 weeks and 3 months, measured by the VAS and Mc Gill Pain Questionary

    Measured: At birth, 6 weeks of age and 3 months of age

  3. Breastfeeding complications

    Presence of crackled nipples, engorgement, mastitis, nipple bleeding, abscess, at birth, 6 weeks and 3 months.

    Measured: At birth, 6 weeks of age and 3 months of age

  4. Infant Breastfeeding Assessment Tool

    Breastfeeding assessed by Infant Breastfeeding Assessment Tool (IBFAT): observational breastfeeding score ranging from 0 to 12 (best score: 12)

    Measured: At birth, 6 weeks of age and 3 months of age

  5. Breastfeding Self-Efficacy Scale - Short Form

    Breastfeeding Self Efficacy ranging from 14 (lower score) to 70 (best score) assessed at birth, at 6 weeks and at 3 months

    Measured: At birth, 6 weeks of age and 3 months of age

  6. Neonatal Oral Motor Assessment Scale (NOMAS),

    Observational scale scoring oral -motor skill as normal, disorganized or dysfunctional (best score: normal)

    Measured: At birth, 6 weeks of age and 3 months of age

  7. Breastfeeding assessment: LATCH score

    LATCH score (observational breastfeeding scale) ranging from 0 to 10 (best score: 10)

    Measured: At birth, 6 weeks of age and 3 months of age

  8. Bristol Breastfeeding Assessment Tool

    Bristol Breastfeeding Assessment Tool (BBAT), observational breatsfeeding scale ranging from 0 to 8 (best score:8).

    Measured: At birth, 6 weeks of age and 3 months of age

  9. Oro facial praxis- Hénin Grid

    At 4 years: in-person assessments will assess speech with :Hénin grid. This grid has standards (acquired - not acquired).

    Measured: At the age of 4 years

  10. Feeding behaviors

    feeding behaviors assessed by structured phone interviews at 6 months, 1 year and 2 years of age.

    Measured: At the age of 6 months, 1 year and 2 years

  11. dental occlusion

    At the age of 4 years dental occlusion will be assessed with the baby-ROMA index.

    Measured: At the age of 4 years

  12. Orofacial praxies - Evalo 2-6

    This grid has standards (acquired - not acquired)

    Measured: At the age of 4 years

  13. Speech

    The NEEL phonological/articulation test will be performed by speech therapists. This test has standards (acquired/ not acquired).

    Measured: At the age of 4 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2026
  2. Study start23 May 2022
  3. Primary completion30 Mar 2025
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
348 participants (actual)
Target duration
4 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT07512765
Sponsor's protocol ID
P2022/167/B4062021000404
Other IDs
Fonds Erasme, Fonds Dr. Daniël De Coninck
Acronym
ANK-PROS
Status last verified
Dec 2025
First submitted
30 Dec 2025
Last updated
6 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data will be shared upon reasonable request. Requests must include a methodologically sound research proposal and will be reviewed by the study sponsor. Data will be shared under a data use agreement to ensure participant confidentiality.

Questions about this trial

What is this clinical trial studying?

An observational study of Ankyloglossia and Breastfeeding, run by Erasme University Hospital at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 6 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Breastfeeding duration (time frame: From enrollment to the end of the study at 4 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in